Copyright Reports & Markets. All rights reserved.

Global Antiinflammatory Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Antiinflammatory Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Antiinflammatory Drugs by Type
    • 1.3.1 Overview: Global Antiinflammatory Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Antiinflammatory Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 Steroidal Anti-Inflammatory Drug
    • 1.3.4 Non-Steroidal Anti-Inflammatory Drug
  • 1.4 Global Antiinflammatory Drugs Market by Application
    • 1.4.1 Overview: Global Antiinflammatory Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Drug Store
    • 1.4.3 Hospital Pharmacies
    • 1.4.4 Online
  • 1.5 Global Antiinflammatory Drugs Market Size & Forecast
  • 1.6 Global Antiinflammatory Drugs Market Size and Forecast by Region
    • 1.6.1 Global Antiinflammatory Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Antiinflammatory Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America Antiinflammatory Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Antiinflammatory Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Antiinflammatory Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America Antiinflammatory Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Antiinflammatory Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Pfizer, Inc
    • 2.1.1 Pfizer, Inc Details
    • 2.1.2 Pfizer, Inc Major Business
    • 2.1.3 Pfizer, Inc Antiinflammatory Drugs Product and Solutions
    • 2.1.4 Pfizer, Inc Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Pfizer, Inc Recent Developments and Future Plans
  • 2.2 Abbvie, Inc
    • 2.2.1 Abbvie, Inc Details
    • 2.2.2 Abbvie, Inc Major Business
    • 2.2.3 Abbvie, Inc Antiinflammatory Drugs Product and Solutions
    • 2.2.4 Abbvie, Inc Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbvie, Inc Recent Developments and Future Plans
  • 2.3 Johnson & Johnson
    • 2.3.1 Johnson & Johnson Details
    • 2.3.2 Johnson & Johnson Major Business
    • 2.3.3 Johnson & Johnson Antiinflammatory Drugs Product and Solutions
    • 2.3.4 Johnson & Johnson Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.4 GlaxoSmithKline
    • 2.4.1 GlaxoSmithKline Details
    • 2.4.2 GlaxoSmithKline Major Business
    • 2.4.3 GlaxoSmithKline Antiinflammatory Drugs Product and Solutions
    • 2.4.4 GlaxoSmithKline Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.5 Merck
    • 2.5.1 Merck Details
    • 2.5.2 Merck Major Business
    • 2.5.3 Merck Antiinflammatory Drugs Product and Solutions
    • 2.5.4 Merck Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Merck Recent Developments and Future Plans
  • 2.6 Novartis
    • 2.6.1 Novartis Details
    • 2.6.2 Novartis Major Business
    • 2.6.3 Novartis Antiinflammatory Drugs Product and Solutions
    • 2.6.4 Novartis Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Novartis Recent Developments and Future Plans
  • 2.7 Almirall
    • 2.7.1 Almirall Details
    • 2.7.2 Almirall Major Business
    • 2.7.3 Almirall Antiinflammatory Drugs Product and Solutions
    • 2.7.4 Almirall Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Almirall Recent Developments and Future Plans
  • 2.8 Abbott
    • 2.8.1 Abbott Details
    • 2.8.2 Abbott Major Business
    • 2.8.3 Abbott Antiinflammatory Drugs Product and Solutions
    • 2.8.4 Abbott Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Abbott Recent Developments and Future Plans
  • 2.9 Zhejiang Jiuzhou Pharmaceutical
    • 2.9.1 Zhejiang Jiuzhou Pharmaceutical Details
    • 2.9.2 Zhejiang Jiuzhou Pharmaceutical Major Business
    • 2.9.3 Zhejiang Jiuzhou Pharmaceutical Antiinflammatory Drugs Product and Solutions
    • 2.9.4 Zhejiang Jiuzhou Pharmaceutical Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments and Future Plans
  • 2.10 Boehringer Ingelheim
    • 2.10.1 Boehringer Ingelheim Details
    • 2.10.2 Boehringer Ingelheim Major Business
    • 2.10.3 Boehringer Ingelheim Antiinflammatory Drugs Product and Solutions
    • 2.10.4 Boehringer Ingelheim Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.11 Jilin Huakang Pharmaceutical
    • 2.11.1 Jilin Huakang Pharmaceutical Details
    • 2.11.2 Jilin Huakang Pharmaceutical Major Business
    • 2.11.3 Jilin Huakang Pharmaceutical Antiinflammatory Drugs Product and Solutions
    • 2.11.4 Jilin Huakang Pharmaceutical Antiinflammatory Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Jilin Huakang Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Antiinflammatory Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Antiinflammatory Drugs by Company Revenue
    • 3.2.2 Top 3 Antiinflammatory Drugs Players Market Share in 2023
    • 3.2.3 Top 6 Antiinflammatory Drugs Players Market Share in 2023
  • 3.3 Antiinflammatory Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Antiinflammatory Drugs Market: Region Footprint
    • 3.3.2 Antiinflammatory Drugs Market: Company Product Type Footprint
    • 3.3.3 Antiinflammatory Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Antiinflammatory Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Antiinflammatory Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Antiinflammatory Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Antiinflammatory Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Antiinflammatory Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America Antiinflammatory Drugs Consumption Value by Application (2019-2030)
  • 6.3 North America Antiinflammatory Drugs Market Size by Country
    • 6.3.1 North America Antiinflammatory Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Antiinflammatory Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Antiinflammatory Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe Antiinflammatory Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe Antiinflammatory Drugs Market Size by Country
    • 7.3.1 Europe Antiinflammatory Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Antiinflammatory Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Antiinflammatory Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Antiinflammatory Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Antiinflammatory Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Antiinflammatory Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Antiinflammatory Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Antiinflammatory Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America Antiinflammatory Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America Antiinflammatory Drugs Market Size by Country
    • 9.3.1 South America Antiinflammatory Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Antiinflammatory Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Antiinflammatory Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Antiinflammatory Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Antiinflammatory Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Antiinflammatory Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Antiinflammatory Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Antiinflammatory Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Antiinflammatory Drugs Market Drivers
  • 11.2 Antiinflammatory Drugs Market Restraints
  • 11.3 Antiinflammatory Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Antiinflammatory Drugs Industry Chain
  • 12.2 Antiinflammatory Drugs Upstream Analysis
  • 12.3 Antiinflammatory Drugs Midstream Analysis
  • 12.4 Antiinflammatory Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Antiinflammatory Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Antiinflammatory Drugs are drug or substance that reduces inflammation (redness, swelling, and pain) in the body.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Antiinflammatory Drugs industry chain, the market status of Drug Store (Steroidal Anti-Inflammatory Drug, Non-Steroidal Anti-Inflammatory Drug), Hospital Pharmacies (Steroidal Anti-Inflammatory Drug, Non-Steroidal Anti-Inflammatory Drug), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiinflammatory Drugs.
    Regionally, the report analyzes the Antiinflammatory Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiinflammatory Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Antiinflammatory Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiinflammatory Drugs industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Steroidal Anti-Inflammatory Drug, Non-Steroidal Anti-Inflammatory Drug).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiinflammatory Drugs market.
    Regional Analysis: The report involves examining the Antiinflammatory Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiinflammatory Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Antiinflammatory Drugs:
    Company Analysis: Report covers individual Antiinflammatory Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiinflammatory Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Drug Store, Hospital Pharmacies).
    Technology Analysis: Report covers specific technologies relevant to Antiinflammatory Drugs. It assesses the current state, advancements, and potential future developments in Antiinflammatory Drugs areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiinflammatory Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Antiinflammatory Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Steroidal Anti-Inflammatory Drug
    Non-Steroidal Anti-Inflammatory Drug
    Market segment by Application
    Drug Store
    Hospital Pharmacies
    Online
    Market segment by players, this report covers
    Pfizer, Inc
    Abbvie, Inc
    Johnson & Johnson
    GlaxoSmithKline
    Merck
    Novartis
    Almirall
    Abbott
    Zhejiang Jiuzhou Pharmaceutical
    Boehringer Ingelheim
    Jilin Huakang Pharmaceutical
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Antiinflammatory Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Antiinflammatory Drugs, with revenue, gross margin and global market share of Antiinflammatory Drugs from 2019 to 2024.
    Chapter 3, the Antiinflammatory Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antiinflammatory Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Antiinflammatory Drugs.
    Chapter 13, to describe Antiinflammatory Drugs research findings and conclusion.

    Buy now